标题
The current role of thiazolidinediones in diabetes management
作者
关键词
Diabetes mellitus, Thiazolidinediones, Rosiglitazone, Pioglitazone, Efficacy, Safety, Cardiovascular effects, Pleiotropic effects
出版物
ARCHIVES OF TOXICOLOGY
Volume 90, Issue 8, Pages 1861-1881
出版商
Springer Nature
发表日期
2016-05-10
DOI
10.1007/s00204-016-1737-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study
- (2016) Jil Mamza et al. ANNALS OF MEDICINE
- Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies
- (2016) Manel Pladevall et al. BMC Cardiovascular Disorders
- Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
- (2016) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor
- (2016) R. A. DeFronzo et al. DIABETES OBESITY & METABOLISM
- Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
- (2016) Devjit Tripathy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
- (2016) Laura Negrotto et al. JAMA Neurology
- Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes
- (2015) Renyuan Li et al. ACTA DIABETOLOGICA
- Effect of pioglitazone medication on the incidence of dementia
- (2015) Michael T. Heneka et al. ANNALS OF NEUROLOGY
- Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
- (2015) Chin-Hsiao Tseng BMC CANCER
- Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
- (2015) H. Florez et al. DIABETES OBESITY & METABOLISM
- Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
- (2015) H Yokoyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Preventing the progression to Type 2 diabetes mellitus in adults at high risk: A systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions
- (2015) John W. Stevens et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
- (2015) Emma O. Billington et al. DIABETOLOGIA
- Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries
- (2015) Elizabeth E. Roughead et al. DRUG SAFETY
- AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- (2015) Alan J. Garber et al. Endocrine Practice
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study
- (2015) Ryota Tanaka et al. Journal of Atherosclerosis and Thrombosis
- Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2015) Sumio Watanabe et al. JOURNAL OF GASTROENTEROLOGY
- The use of oral pioglitazone in the treatment of lichen planopilaris
- (2015) Natasha Atanaskova Mesinkovska et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
- (2015) Stéphane Prost et al. NATURE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone
- (2015) Diogo Mendes et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
- (2015) Sunghwan Suh et al. Diabetes & Metabolism Journal
- Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs
- (2015) Mai M. Helmy et al. PLoS One
- Cancer and bone fractures in observational follow-up of the RECORD study
- (2014) Nigel P. Jones et al. ACTA DIABETOLOGICA
- Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
- (2014) Janaína K. Barbiero et al. BEHAVIOURAL BRAIN RESEARCH
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
- (2014) Zhong-Ning Zhu et al. BONE
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
- (2014) K.-D. Lin et al. DIABETIC MEDICINE
- Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial
- (2014) Z. Punthakee et al. DIABETIC MEDICINE
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease
- (2014) Anna R Carta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Randomized Controlled Trial of the Effects of Pioglitazone Treatment on Sympathetic Nervous System Activity and Cardiovascular Function in Obese Subjects With Metabolic Syndrome
- (2014) Nora E. Straznicky et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study)
- (2014) W. Xu et al. JOURNAL OF INTERNAL MEDICINE
- Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
- (2014) Sang-Man Jin et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome
- (2014) Gaspare Stabile et al. Journal of Pediatric and Adolescent Gynecology
- Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?
- (2014) Jennifer C. Stone et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
- (2014) Mei-Yueh Lee et al. PLoS One
- Pioglitazone Improves Fat Distribution, the Adipokine Profile and Hepatic Insulin Sensitivity in Non-Diabetic End-Stage Renal Disease Subjects on Maintenance Dialysis: A Randomized Cross-Over Pilot Study
- (2014) Anne Zanchi et al. PLoS One
- Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis
- (2014) Yu Lu et al. Journal of Diabetes Investigation
- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
- (2013) Y. Atamer et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis
- (2013) Richard M. Turner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights
- (2013) Carlos Vallarino et al. CLINICAL DRUG INVESTIGATION
- Pioglitazone and Cancer: Angel or Demon?
- (2013) Michael Kostapanos et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
- (2013) G. A. Bray et al. DIABETES OBESITY & METABOLISM
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
- (2013) Fei-Yuan Hsiao et al. DRUG SAFETY
- Drug-Induced Macular Edema
- (2013) Olga E. Makri et al. DRUGS
- Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND
- (2013) Elizabeth R. Seaquist et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
- (2013) C. Bosetti et al. ONCOLOGIST
- Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis
- (2013) Shiyao He et al. TUMOR BIOLOGY
- Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes
- (2012) Iskandar Idris et al. ARCHIVES OF INTERNAL MEDICINE
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
- (2012) I. N. Colmers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
- (2012) Kanta Fujimoto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression
- (2012) Ladan Kashani et al. PSYCHONEUROENDOCRINOLOGY
- The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
- (2012) L. Azoulay et al. BMJ-British Medical Journal
- The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
- (2012) Sun Ok Song et al. Diabetes & Metabolism Journal
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Pioglitazone reduces urinary albumin excretion in renin−angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study
- (2011) Akizuki Morikawa et al. Clinical and Experimental Nephrology
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
- (2011) C. Piccinni et al. DIABETES CARE
- Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus
- (2011) Ligia Petrica et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity
- (2011) David E. Kemp et al. JOURNAL OF AFFECTIVE DISORDERS
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
- (2011) Natalie L. Rasgon et al. TheScientificWorldJOURNAL
- Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
- (2010) Pantelis A. Sarafidis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lack of Association Between Thiazolidinediones and Macular Edema in Type 2 Diabetes
- (2010) Walter T. Ambrosius ARCHIVES OF OPHTHALMOLOGY
- Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial
- (2010) Olivier F. Bertrand et al. ATHEROSCLEROSIS
- The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
- (2010) Kenneth Cusi Current Diabetes Reports
- Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
- (2010) Bernard Zinman et al. LANCET
- Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment
- (2010) Jae Hoon Moon et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus
- (2009) Patrizio Tatti et al. CLINICAL DRUG INVESTIGATION
- How safe is the use of thiazolidinediones in clinical practice?
- (2009) CV Rizos et al. Expert Opinion On Drug Safety
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
- (2009) Tracey M. McLaughlin et al. Obesity
- Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)
- (2008) J.A. Dormandy et al. ATHEROSCLEROSIS
- Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
- (2008) M. Monami et al. DIABETES CARE
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Pleiotropic effects of thiazolidinediones
- (2008) CV Rizos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- General and Abdominal Adiposity and Risk of Death in Europe
- (2008) T. Pischon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation
- (2007) M.P. Khanolkar et al. ATHEROSCLEROSIS
- The effect of thiazolidinediones on adiponectin serum level: a meta-analysis
- (2007) N. Riera-Guardia et al. DIABETES OBESITY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search